Literature DB >> 18954287

The pathology of chronic obstructive pulmonary disease.

James C Hogg1, Wim Timens.   

Abstract

The pathogenesis of chronic obstructive pulmonary disease (COPD) is based on the innate and adaptive inflammatory immune response to the inhalation of toxic particles and gases. Although tobacco smoking is the primary cause of this inhalation injury, many other environmental and occupational exposures contribute to the pathology of COPD. The immune inflammatory changes associated with COPD are linked to a tissue-repair and -remodeling process that increases mucus production and causes emphysematous destruction of the gas-exchanging surface of the lung. The common form of emphysema observed in smokers begins in the respiratory bronchioles near the thickened and narrowed small bronchioles that become the major site of obstruction in COPD. The mechanism(s) that allow small airways to thicken in such close proximity to lung tissue undergoing emphysematous destruction remains a puzzle that needs to be solved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18954287     DOI: 10.1146/annurev.pathol.4.110807.092145

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  220 in total

1.  Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition.

Authors:  Annika B M Åstrand; Martin Hemmerling; James Root; Cecilia Wingren; Jelena Pesic; Edvin Johansson; Alaina L Garland; Arunava Ghosh; Robert Tarran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

2.  Airway count and emphysema assessed by chest CT imaging predicts clinical outcome in smokers.

Authors:  Alejandro A Diaz; Clarissa Valim; Tsuneo Yamashiro; Raúl San José Estépar; James C Ross; Shin Matsuoka; Brian Bartholmai; Hiroto Hatabu; Edwin K Silverman; George R Washko
Journal:  Chest       Date:  2010-06-17       Impact factor: 9.410

Review 3.  Take the Wnt out of the inflammatory sails: modulatory effects of Wnt in airway diseases.

Authors:  Sebastian Reuter; Hendrik Beckert; Christian Taube
Journal:  Lab Invest       Date:  2015-11-23       Impact factor: 5.662

Review 4.  Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).

Authors:  Han Ni; Aung Htet; Soe Moe
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

5.  Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients.

Authors:  Deepti Malhotra; Rajesh K Thimmulappa; Nicolas Mercado; Kazuhiro Ito; Ponvijay Kombairaju; Sarvesh Kumar; Jinfang Ma; David Feller-Kopman; Robert Wise; Peter Barnes; Shyam Biswal
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

6.  Free Desmosine is a Sensitive Marker of Smoke-Induced Emphysema.

Authors:  Jerome Cantor; Arnulfo Ochoa; Shuren Ma; Xingjian Liu; Gerard Turino
Journal:  Lung       Date:  2018-09-14       Impact factor: 2.584

7.  NLRP3 Inflammasome Involves in the Acute Exacerbation of Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Huaying Wang; Chun'er Lv; Shi Wang; Huajuan Ying; Yuesong Weng; Wanjun Yu
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

8.  The Ratio of Free to Bound Desmosine and Isodesmosine May Reflect Emphysematous Changes in COPD.

Authors:  Xingjian Liu; Shuren Ma; Sophie Liu; Ming Liu; Gerard Turino; Jerome Cantor
Journal:  Lung       Date:  2015-03-12       Impact factor: 2.584

Review 9.  What drives the peripheral lung-remodeling process in chronic obstructive pulmonary disease?

Authors:  James C Hogg; John E McDonough; John V Gosselink; Shizu Hayashi
Journal:  Proc Am Thorac Soc       Date:  2009-12

Review 10.  Autophagy in Pulmonary Diseases.

Authors:  Kiichi Nakahira; Maria Angelica Pabon Porras; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.